Freezing prostate cancer: Study shows notable outcomes with cryoablation

September 28, 2020 – A less-invasive treatment technique called hemi-gland cryoablation (HGCryo) – destroying the areas of the prostate where cancers are located by freezing them – provides a high rate of effective prostate cancer control, according to a new study published in The Journal of Urology®, Official Journal of the American Urological Association (AUA).…

Details

New MaskCountTM app allows citizen scientists to contribute to effort to contain COVID-19

INDIANAPOLIS — A new app will allow anyone to contribute real-world data to the effort to understand COVID-19. “MaskCountTM,” from Regenstrief Institute, lets users document the number of people they see wearing or not-wearing masks, all without identifying anyone. This information will be combined for display and analyzed with other COVID-19 data, such as case…

Details

Cincinnati Children’s research helps pave way for newly approved use of drug

Following two decades of research on a group of rare diseases called hypereosinophilic syndrome at Cincinnati Children’s Hospital Medical Center, the U.S. Food and Drug Administration has approved the drug Nucala (mepolizumab) for use in the treatment of patients with hypereosinophilic syndrome. Hypereosinophilic syndrome, also known as HES, is a life-threatening group of blood disorders…

Details

Antacid monotherapy more effective in relieving epigastric pain than in combination with lidocain

DES PLAINES, IL — Antacid monotherapy is more effective in relieving epigastric pain than in combination with lidocaine. That is the conclusion of a study to be published in the September 2020 issue of Academic Emergency Medicine (AEM), a journal of the Society for Academic Emergency Medicine (SAEM). The lead author of the single-center study…

Details